You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Development of Aptamer Affinity Reagents to Immune Targets in Non-human Disease Models

    SBC: BASE PAIR BIOTECHNOLOGIES INC            Topic: NIAID

    This goal of this program is to address the limited availability of reagentsantibodiesproteinsligandsfor the identification and discrimination of immune cells and the characterization of immune responses in nonmammalian models and mammalian models for which immunologic reagents are limitede gguinea pigferretcotton ratFor examplethe progression of disease that follows infection of guinea pigs with ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  2. Fluorescent Qdot Immunochromatographic Test Strips for Influenza A B and Group A Strep

    SBC: NANOHMICS INC            Topic: ODCDC

    Nanohmics proposes to develop ultrasensitive and specific antibody based sandwich lateral flowLFtest strips for influenza A and B hemagglutinins and neuraminidasesas well as Group A StreptococcusSpyogenesfrom throat and nasal swabs or saliva samplesVery good LF test strips are already marketed for these highly important disease analytesBut to improve detectionNanohmics will incorporate fluorescent ...

    SBIR Phase I 2019 Department of Health and Human ServicesCenters for Disease Control and Prevention
  3. Pediatric Opioid Withdrawal Research SystemPOWR System

    SBC: LUNA INNOVATIONS INCORPORATED            Topic: ODCDC

    InoverAmericans died as a result of opioid overdosemaking opioid use the leading cause of death for Americans underThis crisis affects both males and femalesthus leading to a surge in the number of babies born with opioid addictionthe withdrawal from which is termed Neonatal Abstinence SyndromeNASIninstances of newborn opioid dependence were recordedDiagnostic metrics seek to standardize diagnosis ...

    SBIR Phase I 2019 Department of Health and Human ServicesCenters for Disease Control and Prevention
  4. Multiplex Detection of Recent and Prior Exposure to Pathogens

    SBC: LUNA INNOVATIONS INCORPORATED            Topic: ODCDC

    The goal of this project is to solicit the innovative development of diagnostic testing platforms that can simultaneously detect antigens of multiple pathogens and different antibody isotypes and or immune factors against those pathogens in a single multiplex assayThe pathogens of interest includebut are not limited tothose with a high potential for causing global disease outbreaks that affect vul ...

    SBIR Phase I 2019 Department of Health and Human ServicesCenters for Disease Control and Prevention
  5. Multifunctional Cold Chain Container for Unmanned Aerial Vehicle Transport

    SBC: BLOODSTONE DIVISION LLC            Topic: ODCDC

    Development of an agile device that can deliver supplies to and from remote locations during public health emergenciesIn the context of emergency public health responsedrones could be extremely useful for transporting necessary supplies to remote or inaccessible locationsSupplies might include dry goodsbut would certainly include clinical specimensreagent kitsvaccines and other perishable goodsThe ...

    SBIR Phase I 2019 Department of Health and Human ServicesCenters for Disease Control and Prevention
  6. NCATS SBIR 2019 PHASE I PROPOSALS TOPIC 018 ENTITLED NON-PDMS BIOCOMPATIBLE ALTERNATIVES FOR ORGANS-ON-CHIPS

    SBC: LYNNTECH INC.            Topic: NIDA

    Microfluidic organ on a chipOOCsystems offer a distinct advantage over existing in vitro systems through incorporation of micro architecture to a cultured cell line sthat structurely and mechanically mimic more closely in vivo physiological conditions in an in vitro constructThese OOC devices are typically constructed from polydimethylsiloxanePDMShoweverPDMS has several drawbacks that can impact t ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  7. TOPIC 382- INTEGRATED IMAGING AND MOLECULAR ANALYSIS OF GLIOBLASTOMA USING SCOPE SEQ ON THE AIR FLOW

    SBC: CELL MICROSYSTEMS INC            Topic: NCI

    Combining both genomic analysis and highEresolution imaging on a cellEbyEcell basis typically relies on customized technology which often requires significant expertise and capital costCell MicrosystemsInchas partnered with Peter SimsPhD of Columbia University to commercialize a novel workflow for integrated imaging and sample preparation for single cell transcriptomic analysisDrSims workflowSingl ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  8. An integrated device and system for drug detection and deactivation to deter controlled substance theft in hospitals and other healthcare delivery settings.

    SBC: CERTIRX CORPORATION            Topic: NIDA

    Under the Small Business Innovation Research ProgramSBIRPhase I programTopicthe Contractor will develop an integrated device and system for drug detection and deactivation to deter controlled substance theft in hospitals and other healthcare delivery settings

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  9. Rapid Point-of-Care Tests to Simultaneously Quantify Anti-TB Drugs in Blood

    SBC: ZYMERON CORPORATION            Topic: NIAID

    TuberculosisTBis currently the leading infectious cause of death worldwideTB treatment includes multiple different combinations of antibioticsdosesand long time periodsThe current standard includes an intensive phase ofmonthsfollowed by a continuation phase of eitherormonthsHowevertreatment outcome can be poor due to drug drug interactionsimpaired medication adherencedrug absorption and metabolism ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  10. In Vivo Targeted Degradation of HIV Gag Polyprotein by Gag-PROTAC Reagents

    SBC: ZYMERON CORPORATION            Topic: NIAID

    HIV disease continues to be a serious health issue for the whole worldCurrentlyantiretroviral therapyARTis a widely accepted treatment to HIV infected patientswhich reduces morbidity and mortality and the potential for HIV transmission by suppressing viral replicationHowevertreatment outcomes of ART are limited due to the high adherence requirement and occurrence of drug resistanceProteolysis targ ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government